Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management (Q37023974)

17 August 2017

title

Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management (English)

1 reference

17 August 2017

0 references

Lewis S Nelson

10

0 references

Peter A. Chyka

7

object named as

Peter A Chyka

1 reference

17 August 2017

Elizabeth J Scharman

1

1 reference

17 August 2017

Andrew R Erdman

2

1 reference

17 August 2017

Daniel J Cobaugh

3

1 reference

17 August 2017

Kent R Olson

4

1 reference

17 August 2017

Alan D Woolf

5

1 reference

17 August 2017

E Martin Caravati

6

1 reference

17 August 2017

Lisa L Booze

8

1 reference

17 August 2017

Anthony S Manoguerra

9

1 reference

17 August 2017

Gwenn Christianson

11

1 reference

17 August 2017

William G Troutman

12

1 reference

17 August 2017

American Association of Poison Control Centers

13

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

45

1 reference

17 August 2017

issue

7

1 reference

17 August 2017

page(s)

737-752

1 reference

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

National trends in the use of psychotropic medications by children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Poison centers' experience with methylphenidate abuse in pre-teens and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Stimulant therapy and seizure risk in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

ADHD drugs and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Combining Stimulants With Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Abuse and toxicity of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Methylphenidate unintentional ingestion in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

A profile of methylphenidate exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Stimulant treatment over five years: adherence, effectiveness, and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

A postmarketing clinical experience study of Metadate CD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Hemodynamic effects of acute administration of atomoxetine and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Near-fatal methylphenidate misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Pediatric methylphenidate exposures: 7-year experience of poison centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Images in cardiovascular medicine. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Methylphenidate (OROS formulation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

Extended-release methylphenidate (Ritalin LA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650701665175

10.1080/15563650701665175

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference